Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis.

Pepper RJ, McAdoo SP, Moran SM, Kelly D, Scott J, Hamour S, Burns A, Griffith M, Galliford J, Levy JB, Cairns TD, Gopaluni S, Jones RB, Jayne D, Little MA, Pusey CD, Salama AD.

Rheumatology (Oxford). 2019 Feb 1;58(2):373. doi: 10.1093/rheumatology/kez001. No abstract available.

PMID:
30690635
2.

A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis.

Pepper RJ, McAdoo SP, Moran SM, Kelly D, Scott J, Hamour S, Burns A, Griffith M, Galliford J, Levy JB, Cairns TD, Gopaluni S, Jones RB, Jayne D, Little MA, Pusey CD, Salama AD.

Rheumatology (Oxford). 2019 Feb 1;58(2):260-268. doi: 10.1093/rheumatology/key288.

PMID:
30239910
3.

Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma.

van Beers EH, van Vliet MH, Kuiper R, de Best L, Anderson KC, Chari A, Jagannath S, Jakubowiak A, Kumar SK, Levy JB, Auclair D, Lonial S, Reece D, Richardson P, Siegel DS, Stewart AK, Trudel S, Vij R, Zimmerman TM, Fonseca R.

Clin Lymphoma Myeloma Leuk. 2017 Sep;17(9):555-562. doi: 10.1016/j.clml.2017.06.020. Epub 2017 Jul 4.

PMID:
28735890
4.

Treatment-limiting renal tubulopathy in patients treated with tenofovir disoproxil fumarate.

Hamzah L, Jose S, Booth JW, Hegazi A, Rayment M, Bailey A, Williams DI, Hendry BM, Hay P, Jones R, Levy JB, Chadwick DR, Johnson M, Sabin CA, Post FA.

J Infect. 2017 May;74(5):492-500. doi: 10.1016/j.jinf.2017.01.010. Epub 2017 Jan 25.

5.

A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myeloma.

Chari A, Htut M, Zonder JA, Fay JW, Jakubowiak AJ, Levy JB, Lau K, Burt SM, Tunquist BJ, Hilder BW, Rush SA, Walker DH, Ptaszynski M, Kaufman JL.

Cancer. 2016 Nov 15;122(21):3327-3335. doi: 10.1002/cncr.30174. Epub 2016 Jul 19.

6.

Renal effects of novel antiretroviral drugs.

Milburn J, Jones R, Levy JB.

Nephrol Dial Transplant. 2017 Mar 1;32(3):434-439. doi: 10.1093/ndt/gfw064. Review.

7.

Necrotizing and crescentic glomerulonephritis presenting with preserved renal function in patients with underlying multisystem autoimmune disease: a retrospective case series.

McAdoo SP, Tanna A, Randone O, Tam FW, Tarzi RM, Levy JB, Griffith M, Lightstone L, Cook HT, Cairns T, Pusey CD.

Rheumatology (Oxford). 2015 Jun;54(6):1025-32. doi: 10.1093/rheumatology/keu445. Epub 2014 Nov 26.

8.

End-stage kidney disease and kidney transplantation in HIV-positive patients: an observational cohort study.

Gathogo E, Jose S, Jones R, Levy JB, Mackie NE, Booth J, Connolly J, Johnson M, Leen C, Williams D, Sabin CA, Post FA.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):177-80. doi: 10.1097/QAI.0000000000000291.

PMID:
25072607
9.

Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors.

Tanna A, Guarino L, Tam FW, Rodriquez-Cubillo B, Levy JB, Cairns TD, Griffith M, Tarzi RM, Caplin B, Salama AD, Cook T, Pusey CD.

Nephrol Dial Transplant. 2015 Jul;30(7):1185-92. doi: 10.1093/ndt/gfu237. Epub 2014 Jul 12.

10.

Kidney transplantation in HIV-positive adults: the UK experience.

Gathogo EN, Hamzah L, Hilton R, Marshall N, Ashley C, Harber M, Levy JB, Jones R, Boffito M, Khoo SH, Drage M, Bhagani S, Post FA; UK HIV/Kidney Transplantation Study Group (see appendix).

Int J STD AIDS. 2014 Jan;25(1):57-66. doi: 10.1177/0956462413493266. Epub 2013 Jul 19.

PMID:
23970634
11.

Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.

Condon MB, Ashby D, Pepper RJ, Cook HT, Levy JB, Griffith M, Cairns TD, Lightstone L.

Ann Rheum Dis. 2013 Aug;72(8):1280-6. doi: 10.1136/annrheumdis-2012-202844. Epub 2013 Jun 5.

PMID:
23740227
12.

Clinical outcomes of a combined HIV and renal clinic.

McClure M, Singh GJ, Rayment M, Jones R, Levy JB.

Clin Kidney J. 2012 Dec;5(6):530-4. doi: 10.1093/ckj/sfs141. Epub 2012 Nov 9.

13.

Plasmapheresis in immunologic renal disease.

Pusey CD, Levy JB.

Blood Purif. 2012;33(1-3):190-8. doi: 10.1159/000334155. Epub 2012 Jan 20. Review.

14.

An atypical cutaneous presentation of vasculitis with features of Churg-Strauss syndrome, associated with anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane antibodies.

Gleeson CM, Levy JB, Cook HT, Francis ND, Robson A, Pope FM.

Clin Exp Dermatol. 2009 Dec;34(8):e577-80. doi: 10.1111/j.1365-2230.2009.03248.x. Epub 2009 Jun 24.

PMID:
19558532
15.

Enuresis.

Graham KM, Levy JB.

Pediatr Rev. 2009 May;30(5):165-72; quiz 173. doi: 10.1542/pir.30-5-165. Review. No abstract available. Erratum in: Pediatr Rev. 2009 Sep;30(9):369.

PMID:
19411333
16.

Metformin: effective and safe in renal disease?

Herrington WG, Levy JB.

Int Urol Nephrol. 2008;40(2):411-7. doi: 10.1007/s11255-008-9371-6. Review.

PMID:
18368503
17.

Is there a role for intensive insulin therapy in patients with kidney disease?

Ritchie-McLean S, Kirwan C, Levy JB.

Am J Kidney Dis. 2007 Sep;50(3):371-8. Review.

PMID:
17720516
18.

Impact of new dialysis solutions on peritonitis rates.

Ahmad S, Sehmi JS, Ahmad-Zakhi KH, Clemenger M, Levy JB, Brown EA.

Kidney Int Suppl. 2006 Nov;(103):S63-6.

PMID:
17080113
19.

Fluorodeoxyglucose positron emission tomography detects the inflammatory phase of sclerosing peritonitis.

Tarzi RM, Frank JW, Ahmad S, Levy JB, Brown EA.

Perit Dial Int. 2006 Mar-Apr;26(2):224-30.

PMID:
16623430
20.

Emphysematous cystitis.

Nemati E, Basra R, Fernandes J, Levy JB.

Nephrol Dial Transplant. 2005 Mar;20(3):652-3. No abstract available.

PMID:
15735251
21.

Clinical features and outcome of patients with both ANCA and anti-GBM antibodies.

Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD.

Kidney Int. 2004 Oct;66(4):1535-40.

22.

Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.

Tam FW, Sanders JS, George A, Hammad T, Miller C, Dougan T, Cook HT, Kallenberg CG, Gaskin G, Levy JB, Pusey CD.

Nephrol Dial Transplant. 2004 Nov;19(11):2761-8. Epub 2004 Sep 7.

PMID:
15353578
23.

Neurological complications from brachial arteriovenous fistulae.

Reyal Y, Robinson C, Salama A, Levy JB.

Nephrol Dial Transplant. 2004 Jul;19(7):1923-4. No abstract available.

PMID:
15199202
24.

Supportive care for the renal patient.

Levy JB, Chambers EJ, Brown EA.

Nephrol Dial Transplant. 2004 Jun;19(6):1357-60. Epub 2004 Mar 5. No abstract available.

PMID:
15004252
25.

Tolerance and autoimmunity in anti-GBM disease.

Salama AD, Levy JB.

J Am Soc Nephrol. 2003 Nov;14(11):2988-9. No abstract available.

26.

Characterization of autoantibodies from patients with Goodpasture's disease using a resonant mirror biosensor.

Dougan T, Levy JB, Salama A, George AJ, Pusey CD.

Clin Exp Immunol. 2002 Jun;128(3):555-61.

27.

Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques.

Salama AD, Dougan T, Levy JB, Cook HT, Morgan SH, Naudeer S, Maidment G, George AJ, Evans D, Lightstone L, Pusey CD.

Am J Kidney Dis. 2002 Jun;39(6):1162-7.

PMID:
12046026
28.

Molecular complexes that contain both c-Cbl and c-Src associate with Golgi membranes.

Bard F, Patel U, Levy JB, Jurdic P, Horne WC, Baron R.

Eur J Cell Biol. 2002 Jan;81(1):26-35. Erratum in: Eur J Cell Biol 2002 Mar;81(3):174.

PMID:
11893076
29.

Goodpasture's disease.

Salama AD, Levy JB, Lightstone L, Pusey CD.

Lancet. 2001 Sep 15;358(9285):917-20. No abstract available. Erratum in: Lancet 2001 Oct 20;358(9290):1374.

PMID:
11567730
30.

In Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1.

Salama AD, Chaudhry AN, Ryan JJ, Eren E, Levy JB, Pusey CD, Lightstone L, Lechler RI.

J Am Soc Nephrol. 2001 Sep;12(9):1908-15.

31.

Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.

Levy JB, Turner AN, Rees AJ, Pusey CD.

Ann Intern Med. 2001 Jun 5;134(11):1033-42.

PMID:
11388816
32.

Nephrotoxicity of intravenous immunoglobulin.

Levy JB, Pusey CD.

QJM. 2000 Nov;93(11):751-5.

PMID:
11077032
33.

Images in nephrology. Recurrence of psoriasis in an arteriovenous fistula.

Levy JB, Clutterbuck EJ.

Nephrol Dial Transplant. 1999 Nov;14(11):2738-9. No abstract available.

PMID:
10534524
34.

The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice.

Aoki K, Didomenico E, Sims NA, Mukhopadhyay K, Neff L, Houghton A, Amling M, Levy JB, Horne WC, Baron R.

Bone. 1999 Sep;25(3):261-7.

PMID:
10495129
35.

Urological complications after kidney-pancreas transplantation.

Gettman MT, Levy JB, Engen DE, Nehra A.

J Urol. 1998 Jan;159(1):38-42; discussion 42-3.

PMID:
9400432
36.

Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts.

Insogna KL, Sahni M, Grey AB, Tanaka S, Horne WC, Neff L, Mitnick M, Levy JB, Baron R.

J Clin Invest. 1997 Nov 15;100(10):2476-85.

37.

Mapping B cell epitopes in Goodpasture's disease.

Levy JB, Coulthart A, Pusey CD.

J Am Soc Nephrol. 1997 Nov;8(11):1698-705.

38.

Modified pudendal-thigh flap for correction of penoscrotal transposition.

Levy JB, Darson MF, Bite U, Kramer SA.

Urology. 1997 Oct;50(4):597-600.

PMID:
9338739
39.

Hypertension after surgical management of renal duplication associated with an upper pole ureterocele.

Levy JB, Vandersteen DR, Morgenstern BZ, Husmann DA.

J Urol. 1997 Sep;158(3 Pt 2):1241-4.

PMID:
9258184
40.

Genitourinary neurofibromatosis mimicking posterior urethral valves.

Brown JA, Levy JB, Kramer SA.

Urology. 1997 Jun;49(6):960-2.

PMID:
9187712
41.

Recurrent glomerulonephritis following renal transplantation.

Kotanko P, Pusey CD, Levy JB.

Transplantation. 1997 Apr 27;63(8):1045-52. Review. No abstract available.

PMID:
9133463
42.

Still a role for plasma exchange in rapidly progressive glomerulonephritis?

Levy JB, Pusey CD.

J Nephrol. 1997 Jan-Feb;10(1):7-13. Review.

PMID:
9241619
43.

Identification of a novel 135-kDa Grb2-binding protein in osteoclasts.

Sahni M, Zhou XM, Bakiri L, Schlessinger J, Baron R, Levy JB.

J Biol Chem. 1996 Dec 20;271(51):33141-7.

44.

c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption.

Tanaka S, Amling M, Neff L, Peyman A, Uhlmann E, Levy JB, Baron R.

Nature. 1996 Oct 10;383(6600):528-31.

PMID:
8849724
45.

Epitope analysis of the Goodpasture antigen using a resonant mirror biosensor.

Levy JB, Turner AN, George AJ, Pusey CD.

Clin Exp Immunol. 1996 Oct;106(1):79-85.

46.

Congenital adrenal hyperplasia: is there an effect on penile growth?

Levy JB, Husmann DA.

J Urol. 1996 Aug;156(2 Pt 2):780-2.

PMID:
8683782
47.

The effects of androgen administration on phallic androgen receptor expression.

Levy JB, Seay TM, Tindall DJ, Husmann DA.

J Urol. 1996 Aug;156(2 Pt 2):775-9.

PMID:
8683781
49.

Recurrent Goodpasture's disease.

Levy JB, Lachmann RH, Pusey CD.

Am J Kidney Dis. 1996 Apr;27(4):573-8. Review.

PMID:
8678069
50.

Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells.

Levy JB, Schindler C, Raz R, Levy DE, Baron R, Horowitz MC.

Endocrinology. 1996 Apr;137(4):1159-65.

PMID:
8625884

Supplemental Content

Support Center